Zobrazeno 1 - 10
of 38
pro vyhledávání: '"S. J. van Hal"'
Autor:
Randy Taplitz, Shmuel Shoham, Alexander Burchardt, Marisa H. Miceli, Sharon L. Reed, Martin Christner, Melina Heinemann, Sanjay Mehta, B. Kemmerling, D. Deeren, A Jover Sáenz, Martin Hoenigl, Livio Pagano, Joerg Steinmann, Monica A. Slavin, J. Baddley, Danila Seidel, Saima Aslam, Jeffrey D. Jenks, Oliver A. Cornely, Raoul Herbrecht, S.G. Revankar, S. J. van Hal, Sharon C.-A. Chen, Sandra Gräber, Carol A. Kauffman
Objectives Lomentospora prolificans is an emerging cause of serious invasive fungal infections. Optimal treatment of these infections is unknown, although voriconazole-containing treatment regimens are considered the treatment of choice. The objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07209ee37daa53542a038e536d53826a
https://www.ncbi.nlm.nih.gov/pubmed/31972317
https://www.ncbi.nlm.nih.gov/pubmed/31972317
Autor:
K. McDonald, Karina Kennedy, Tania C. Sorrell, H. L. Wilson, S. C-A. Chen, Narin Bak, Sarah E. Kidd, Monica A. Slavin, Alun Pope, Krispin Hajkowicz, Deborah Marriott, Neil Underwood, Belinda Chapman, Caitlin Keighley, Catriona Halliday, Quoc Nguyen, S. J. van Hal, Jai N Darvall
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-10 (2019)
Background Candidaemia is associated with high mortality. Variables associated with mortality have been published previously, but not developed into a risk predictive model for mortality. We sought to describe the current epidemiology of candidaemia
Autor:
Sanmarie Schlebusch, Gareth Price, Deon J. Venter, Liam D. H. Elbourne, Renee Gallagher, Slade O. Jensen, V. Horton-Szar, Paul M. Griffin, S. J. van Hal
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 36:495-499
The use of MALDI-TOF MS (matrix-assisted laser desorption/ ionization-time of flight mass spectrometry) and WGS (whole genome sequencing) has been described for identification and strain relatedness determination. We describe the complementary use of
Autor:
C.L. Halliday, Sau-Chin Chen, Tania C. Sorrell, Sarah E. Kidd, Karina Kennedy, C. Blyth, C.H. Heath, Christopher C Blyth, Tony M. Korman, R. Beresford, David Looke, Christopher H. Heath, Michelle Ananda-Rajah, S. Kidd, Narin Bak, Catriona Halliday, Brendan McMullan, Wieland Meyer, Kathryn Daveson, Monica A. Slavin, Elaine Y-L Cheong, Joseph G. McCormack, Eugene Athan, Arthur J. Morris, Steve Chambers, Weiland Meyer, C. Orla Morrissey, Monica A Slavin, E. Geoffrey Playford, Krispin Hajkowicz, Deborah Marriott, Deborrah J Marriott, Sebastian Van Hal, S. J. van Hal, Sharon C.-A. Chen, T.C. Sorrell, Belinda Chapman, Andie S Lee, Ian Arthur, Julia E Clark, J.O. Robinson, C. O. Morrissey, Thomas Gottlieb, N. Bak, K. Daveson
Publikováno v:
Clinical Microbiology and Infection. 22:775-781
Mucormycosis is the second most common cause of invasive mould infection and causes disease in diverse hosts, including those who are immuno-competent. We conducted a multicentre retrospective study of proven and probable cases of mucormycosis diagno
Autor:
Jason A Trubiano, David C. M. Kong, Leon J Worth, Karen F Urbancic, S. J. van Hal, J R Wilkes, Jason A. Roberts, M. Cassumbhoy, Celia Cooper, Deborah Marriott, M. M. Chau
Publikováno v:
Internal Medicine Journal. 44:1364-1388
Antifungal agents may be associated with significant toxicity or drug interactions leading to sub-therapeutic antifungal drug concentrations and poorer clinical outcomes for patients with haematological malignancy. These risks may be minimised by cli
Autor:
Jeff Szer, Monica A. Slavin, Karin A Thursky, Nicole Gilroy, S. J. van Hal, Sharon C.-A. Chen, Leon J Worth, Constantine S. Tam, C. O. Morrissey
Publikováno v:
Internal Medicine Journal. 44:1277-1282
This article reports the findings of a survey developed to assess the current use of antifungal prophylaxis among haematology and infectious disease clinicians across Australia and New Zealand, and their alignment with existing consensus guidelines f
Publikováno v:
Clinical Microbiology and Infection. 20:O1098-O1105
Despite recent controversies about toxicity and reduced efficacy, vancomycin remains the current treatment of choice for methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia. The parameter associated with treatment success is the vancomycin
Autor:
Gabrielle M Haeusler, Jeff Szer, Monica A. Slavin, C. O. Morrissey, Robert Weinkove, Christopher H. Heath, Costas K Yannakou, Sam Milliken, S. J. van Hal, Sharon C.-A. Chen, Shaun Fleming, Andrew Grigg, Constantine S. Tam, Julia E Clark, Ashish Bajel
Publikováno v:
Internal Medicine Journal. 44:1283-1297
There is a strong argument for the use of antifungal prophylaxis in high-risk patients given the significant mortality associated with invasive fungal disease, the late identification of these infections, and the availability of safe and well-tolerat
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
Unlike vancomycin trough concentrations, data on the utility of vancomycin pharmacokinetic (PK) parameters, namely, the area under the concentration-time curve from 0 to 24 h (AUC 0–24 ), in predicting acute kidney injury (AKI) are limited. Our aim
Publikováno v:
Antimicrobial agents and chemotherapy. 61(5)
Unlike vancomycin trough concentrations, data on the utility of vancomycin pharmacokinetic (PK) parameters, namely, the area under the concentration-time curve from 0 to 24 h (AUC0–24), in predicting acute kidney injury (AKI) are limited. Our aim w